Wanted pages

Jump to navigation Jump to search

List of non-existing pages with the most links to them, excluding pages which only have redirects linking to them. For a list of non-existent pages that have redirects linking to them, see the list of broken redirects.

Showing below up to 50 results in range #701 to #750.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Ticilimumab (2 links)
  2. Tigatuzumab (2 links)
  3. Tildrakizumab (2 links)
  4. Timolumab (2 links)
  5. Tisotumab vedotin (2 links)
  6. Tissue factor pathway inhibitor (2 links)
  7. Tocilizumab (2 links)
  8. Toralizumab (2 links)
  9. Tosatoxumab (2 links)
  10. Tositumomab (2 links)
  11. Tovetumab (2 links)
  12. Tralokinumab (2 links)
  13. Transplant rejection (2 links)
  14. Trastuzumab (2 links)
  15. Trastuzumab emtansine (2 links)
  16. Traumatic shock (2 links)
  17. Tregalizumab (2 links)
  18. Tremelimumab (2 links)
  19. Trevogrumab (2 links)
  20. Tucotuzumab celmoleukin (2 links)
  21. Tumor-associated glycoprotein 72 (2 links)
  22. Tumor antigen (2 links)
  23. Tumor endothelial marker 1 (2 links)
  24. Tumor necrosis factor receptor (2 links)
  25. Tuvirumab (2 links)
  26. Ublituximab (2 links)
  27. Ulcerative colitis (2 links)
  28. Ulocuplumab (2 links)
  29. Urelumab (2 links)
  30. Urtoxazumab (2 links)
  31. Ustekinumab (2 links)
  32. Utomilumab (2 links)
  33. Uveitis (2 links)
  34. VEGF-A (2 links)
  35. VEGFR-1 (2 links)
  36. VEGFR2 (2 links)
  37. Vadastuximab talirine (2 links)
  38. Vandortuzumab vedotin (2 links)
  39. Vantictumab (2 links)
  40. Vanucizumab (2 links)
  41. Vapaliximab (2 links)
  42. Varlilumab (2 links)
  43. Vascular endothelial growth factor A (2 links)
  44. Vatelizumab (2 links)
  45. Vedolizumab (2 links)
  46. Veltuzumab (2 links)
  47. Vepalimomab (2 links)
  48. Vesencumab (2 links)
  49. Vimentin (2 links)
  50. Visilizumab (2 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://eln.excellgen.com/index.php?title=Special:WantedPages"